CN Patent
CN115634198A — 用于水难溶性物质的溶媒组合物及其制备方法与应用
Assigned to Zhejiang Beiling Biomedical Co ltd · Expires 2023-01-24 · 3y expired
What this patent protects
本发明涉及一种用于水难溶性物质的溶媒组合物及其制备方法与应用,以帮助水难溶性药物均匀分散于溶媒中,准确分剂量并方便给药,其中所述的水难溶性药物是根据生物药剂学分类系统来定义的。适合于本发明制备的口服混悬溶媒和/或果味溶媒配合使用的药品包括儿科药物、膳食添加剂等,适合需要分剂量和对于吞咽困难的病人。
USPTO Abstract
本发明涉及一种用于水难溶性物质的溶媒组合物及其制备方法与应用,以帮助水难溶性药物均匀分散于溶媒中,准确分剂量并方便给药,其中所述的水难溶性药物是根据生物药剂学分类系统来定义的。适合于本发明制备的口服混悬溶媒和/或果味溶媒配合使用的药品包括儿科药物、膳食添加剂等,适合需要分剂量和对于吞咽困难的病人。
Drugs covered by this patent
- Zestril (lisinopril) · Generic (originally Merck/AstraZeneca)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.